Bloomberg Market Insights: Will the SpaceX IPO Shift the Stock Market Tide? Top Picks for 2026

temp_image_1780986174.600815 Bloomberg Market Insights: Will the SpaceX IPO Shift the Stock Market Tide? Top Picks for 2026

The Collision of Demand and Supply: A New Era for North American Equities

In recent months, investors have exhibited what can only be described as “rabidly enthusiastic demand” for equities. This surge has propelled major indices, including the S&P 500 and the S&P TSX Composite, to unprecedented all-time highs. However, as frequently noted in Bloomberg financial analyses, market equilibrium is a delicate balance between supply and demand.

We are now approaching a pivotal moment where this intense demand will collide with an unprecedented supply of new shares. The most significant catalyst? The upcoming SpaceX IPO, targeting a staggering US$75 billion offering—potentially the largest in history. With OpenAI trailing close behind and Alphabet seeking to raise US$80 billion through secondary equity offerings, the market is about to be flooded with high-profile assets.

The big question for investors is whether these “blockbuster” IPOs will create a halo effect, driving more capital into similar tech-driven businesses, or if they will siphon liquidity away from existing market leaders.

Top Stock Picks for the Current Cycle

Amidst this volatility, certain companies stand out for their fundamental strength and growth potential. Here are three top recommendations for a diversified North American portfolio:

1. Eli Lilly (LLY NYSE): The Healthcare Innovator

Eli Lilly is currently dominating the conversation thanks to its groundbreaking GLP-1 drugs (Zepbound and Mounjaro). But the company’s value extends far beyond the weight-loss craze.

  • Market Dominance: Huge addressable markets in obesity and diabetes, both in the U.S. and internationally.
  • Patent Protection: With a high percentage of biologics and long remaining patent lives, Lilly is better shielded from “patent cliffs” than its competitors.
  • Strategic Growth: A massive M&A strategy, investing over US$18 billion in biotech deals to ensure a robust R&D pipeline.

2. Netflix (NFLX NASDAQ): The Streaming Titan

With a growing subscriber base of 325 million, Netflix has solidified its position as the global leader in high-quality video content. Unlike its competitors, Netflix possesses genuine pricing power and industry-leading customer retention.

Key growth drivers include:

  • Diversified Revenue: Expansion into live events, podcasts, and a successful ad-supported tier.
  • Financial Efficiency: Strong expense management leading to expanded margins and aggressive share repurchases.
  • Valuation: Trading at roughly 22 times earnings, the stock is significantly below its five-year average, offering a compelling entry point.

3. Constellation Software (CSU TSX): The Canadian Powerhouse

For those looking at the TSX, Constellation Software remains a gold standard. This holding company specializes in acquiring mission-critical vertical market software (VMS) companies.

Despite the recent “AI panic” that temporarily suppressed its share price, Constellation’s decentralized operating philosophy continues to deliver results. The company has recently pivoted toward becoming a “permanently engaged minority shareholder,” taking strategic stakes in public software firms—a move that is already regaining investor confidence.

Final Thoughts on the 2026 Outlook

While the excitement surrounding mega-IPOs can be distracting, the key to long-term success remains focusing on companies with strong free cash flow, pricing power, and sustainable competitive advantages. Whether you are tracking the latest trends via Bloomberg or analyzing the TSX, the goal is to find value before the broader market catches on.

Scroll to Top